The global drug-eluting stent market is anticipated to grow at a considerable CAGR of 7.6% during the forecast period (2024-2031). The market growth is attributed to the expanding trend in FDA approvals. As the regulatory body grants more approvals for such stents, it indicates increased acceptance and trust in the safety and efficacy of drug-eluting stents. This positive regulatory...